BrightGene Bio Medical Technology C (688166) — Net Asset Momentum
BrightGene Bio Medical Technology C (688166) recorded a net asset momentum of 0.8% as of December 2024, with net assets of CN¥2.44 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See BrightGene Bio Medical Technology C liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
BrightGene Bio Medical Technology C Net Asset Momentum (2016–2024)
This chart tracks BrightGene Bio Medical Technology C's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is +0.8%, with net assets of CN¥2.44 Billion CNY as of December 2024. Read 688166 total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for BrightGene Bio Medical Technology C (2016–2024)
The table below shows the complete annual net asset history for BrightGene Bio Medical Technology C from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 688166 market cap overview.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥2.44 Billion | CN¥5.16 Billion | CN¥2.73 Billion | ▲ +0.8% |
| 2023 | CN¥2.42 Billion | CN¥5.03 Billion | CN¥2.61 Billion | ▲ +7.8% |
| 2022 | CN¥2.24 Billion | CN¥4.66 Billion | CN¥2.42 Billion | ▲ +28.7% |
| 2021 | CN¥1.74 Billion | CN¥2.97 Billion | CN¥1.23 Billion | ▲ +21.6% |
| 2020 | CN¥1.43 Billion | CN¥1.83 Billion | CN¥395.23 Million | ▲ +9.1% |
| 2019 | CN¥1.31 Billion | CN¥1.42 Billion | CN¥108.21 Million | ▲ +69.9% |
| 2018 | CN¥772.85 Million | CN¥878.37 Million | CN¥105.52 Million | ▲ +73.3% |
| 2017 | CN¥446.02 Million | CN¥524.92 Million | CN¥78.89 Million | ▲ +102.6% |
| 2016 | CN¥220.15 Million | CN¥384.19 Million | CN¥164.05 Million | — |